Keyword: prescription drugs
Capping the Sky (9/11/2007)
Death-postponing cancer drugs command high prices because of the third-party payment health insurance system.
Keywords: cancer drugs, co-payments, drug prices, health insurance, prescription drugs, price cap, price discrimination, third party payment
From Brands to Generics - No Monopoly, No Competition (7/31/2002)
By providing incentives for brand-name drug companies to fund expensive R&D, temporary patents for expensive blockbuster drugs inadvertently lead to cheaper generic rivals when the patents expire.
Keywords: bioequivalent, brand-name drugs, competition, Generic drugs, Hatch-Waxman Act, monopoly, patent, prescription drugs
Market Intervention and Regulation (7/7/2006)
Market regulation may be justified under some circumstances to increase economic efficiency.
Keywords: antitrust, asymmetric information, commons goods, cost effectiveness, intervention, lemons, market, pollution, prescription drugs, public goods, Regulation
Power Play (7/31/2002)
Market competition requires a balance of power between buyers and sellers.
Keywords: balance of power, brand-name drugs, Generic drugs, Hatch-Waxman Act, HMO, managed care, patent, prescription drugs, Prozac